| Kenneth H Prushik, MD | |
|
1994 Wellness Blvd Ste 110, Monroe, NC 28110-7768 | |
| (704) 384-8460 | |
| Not Available |
| Full Name | Kenneth H Prushik |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1994 Wellness Blvd Ste 110, Monroe, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740290162 | NPI | - | NPPES |
| 0600898 | Other | NY | GHI |
| 556Y51 | Other | NY | BLUE CROSS/ BLUE SHIELD |
| 02461633 | Medicaid | NY | |
| 3C3318 | Other | NY | HEALTHNET |
| P2939540 | Other | NY | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2018-00935 (North Carolina) | Primary |
| 2080A0000X | Pediatrics - Adolescent Medicine | 228253-1 (New York) | Secondary |
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
A protein that plays an important regulatory role in heart failure in the heart also exerts powerful effects on the adrenal gland, Jefferson Medical College researchers have found. The protein, GRK2, is a potential drug target for heart failure.
A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy.
In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. Writing in the January 6, 2015 issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging - and may have significant implications for how patients with prostate cancer are ultimately treated.
The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.
AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth H Prushik, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: () - | Kenneth H Prushik, MD 1994 Wellness Blvd Ste 110, Monroe, NC 28110-7768 Ph: (704) 384-8460 |
News Archive
A protein that plays an important regulatory role in heart failure in the heart also exerts powerful effects on the adrenal gland, Jefferson Medical College researchers have found. The protein, GRK2, is a potential drug target for heart failure.
A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy.
In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. Writing in the January 6, 2015 issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging - and may have significant implications for how patients with prostate cancer are ultimately treated.
The Global Alliance for TB Drug Development and Drugs for Neglected Diseases initiative announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases. The TB Alliance has granted rights to DNDi to develop a class of potential anti-TB compounds that also show significant promise for treating other neglected diseases that largely affect the world's poor.
AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.
› Verified 4 days ago
Dr. Robert John Kadijevic, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1328 Patterson Street, Union Pediatrics, Monroe, NC 28112 Phone: 704-283-2000 Fax: 704-225-0885 | |
Dr. Garnet D Maharajh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1994 Wellness Blvd, Suite 110, Monroe, NC 28110 Phone: 704-384-8460 Fax: 704-384-8465 | |
Dr. Deborah Queen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1994 Wellness Blvd, Suite 110, Monroe, NC 28110 Phone: 704-384-8460 Fax: 704-384-8465 | |
Debbie Chavez-mitchell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3173 W Highway 74, Monroe, NC 28110 Phone: 704-283-2000 | |
Dr. Laura Taylor Pridemore, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1994 Wellness Blvd Ste 110, Monroe, NC 28110 Phone: 704-384-8460 Fax: 704-384-8465 | |
Erin Lee Washburn, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1994 Wellness Blvd Ste 110, Monroe, NC 28110 Phone: 704-384-8460 | |
Dr. George P Thevaos, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1994 Wellness Blvd, Suite 110, Monroe, NC 28110 Phone: 704-384-8460 Fax: 704-384-8465 |